ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search
  • 2022 American Transplant Congress

    Outcomes Following Renal Transplant with Hepatitis C Viremic Donors in an Elderly Veteran Population with Preemptive Mayvret Therapy

    R. Lopez-Soler1, A. Thorndyke1, C. Trotter1, A. Abadier2, M. Samra1

    1Surgery, Transplantation, Edward Hines Jr. Veterans Administration Hospital, Hines, IL, 2Surgery, Loyola University School of Medicine, Maywood, IL

    *Purpose: Overall mortality on the kidney transplant waiting list is higher for older diabetic patients. The average age of waitlisted veteran patients is 64, with…
  • 2022 American Transplant Congress

    Older Living Donor Kidneys Are Associated with Worse Recipient and Graft Survival Compared to Younger Donors

    A. P. Bregman1, R. Spong1, R. El-Rifai1, K. Swanson1, S. Jackson2, S. Riad1

    1Medicine, University of Minnesota, Minneapolis, MN, 2Analytics, Mhealth-Fairview, Minneapolis, MN

    *Purpose: Older living donors (LDs) are accepted more frequently to expand the donor pool. We sought to evaluate recipient outcomes from older LDs >70y.*Methods: Utilizing…
  • 2022 American Transplant Congress

    Rates Of Dermatology Follow-up And New Skin Cancer Diagnosis Among Solid Organ Transplant Recipients During The Covid-19 Pandemic

    R. Saranath, J. Gomez, B. Fernandez, E. Shah, S. Michalak, I. Ahronowitz

    USC Keck School of Medicine, Los Angeles, CA

    *Purpose: Solid organ transplant recipients (SOTRs) are at an elevated risk of developing non-melanoma skin cancers. Routine dermatologic surveillance has been shown to improve skin…
  • 2022 American Transplant Congress

    Solid Organ Pancreas Transplantation Offers Superior Glycemic Control Compared to State of the Art Insulin Delivery with Continuous Glucose Monitoring (CGM)

    K. R. McCune, G. K. Dube, P. R. Sandoval, L. E. Ratner

    Columbia University, New York, NY

    *Purpose: Advanced insulin delivery systems with CGM fail to keep serum glucose within range (70-180 mmol/L) 30-40% of the time resulting in Hgb A1C goals…
  • 2022 American Transplant Congress

    Renal Function After Orthotopic Liver Transplantation

    N. Kemmer1, z. Alam2, S. Desai3, L. Grater4, K. Robichaux5, S. Mohammed5, M. Gosselin4, A. Kumar6, J. Buggs7

    1Transplant Hepatology, Tampa General Hospital, Tampa, FL, 2Lake Erie College of Osteopathic Medicine, Bradenton, FL, 3Western University of Osteopathic Medicine, Pomona, CA, 4University of Tampa, Tampa, FL, 5University of South Florida, Tampa, FL, 6Morsani College of Medicine, University of South Florida, Tampa, FL, 7Transplant Surgery, Tampa General Hospital, Tampa, FL

    *Purpose: Patients with end-stage liver disease are susceptible to renal dysfunction especially during liver transplantation (LTX). Continuous renal replacement therapy (CRRT) can be used to…
  • 2022 American Transplant Congress

    Establishment of an In Vitro Assay to Evaluate Indirect T-cell Allo-Response Using Donor PBMC-Pulsed Dendritic Cells

    K. Iwasaki1, T. Tomosugi2, T. Sekiya3, H. Hamana4, Y. Miwa1, K. Futamura2, M. Okada2, T. Hiramitsu2, N. Goto2, S. Narumi2, Y. Watarai2, H. Kishi4, M. Okumura5, S. Ashimine5, K. Ishiyama5, T. Kobayashi5

    1Department of Kidney Diseases and Transplant Immunology, Aichi Medical University School of Medicine, Nagakute, Japan, 2Department of Transplant Surgery, Japanese Red Cross Aichi Medical Center Nagoya Daini Hospital, Nagoya, Japan, 3Department of Immune Regulation, The Research Center for Hepatitis and Immunology, Ichikawa, Japan, 4Department of Immunology, University of Toyama, Toyama, Japan, 5Department of Renal Transplant Surgery, Aichi Medical University School of Medicine, Nagakute, Japan

    *Purpose: Conventional MLR-based methods which evaluate donor-specific immune response via direct T-cell recognition pathway have been reported to be useful in predicting acute TCMR. However,…
  • 2022 American Transplant Congress

    A Intention-to-Treat Analysis of 881 Consecutively Waitlisted Patients to Develop a Survival Benefit Model for Hepatocellular Carcinoma Liver Transplant Candidates

    B. V. Tran1, W. Lapisatepun1, W. Dumronggittigule1, D. Markovic2, Y. Lee1, F. Kaldas1, D. Farmer1, R. Busuttil1, V. Agopian1

    1Department of Surgery, University of California Los Angeles, Los Angeles, CA, 2Department of Medicine, Statistics Core, University of California Los Angeles, Los Angeles, CA

    *Purpose: The current liver transplantation (LT) selection paradigm for hepatocellular carcinoma (HCC) patients ignores the variable risks of waitlist dropout and post-LT recurrence/death, with the…
  • 2022 American Transplant Congress

    Antibody Response to Sars- Cov -2 Mrna Vaccine in Kidney Transplant Recipients

    R. Mohamed Abdul Rahman, M. Alkadi, E. Abuhelaiqa, M. Jarman, A. Nauman, O. Fituri, M. Asim, A. Hamad, H. Tohid, P. Coyle, L. Abu Raddad, H. Al-Malki

    Nephrology, Hamad Medical Corporation, Doha, Qatar

    *Purpose: Kidney transplant recipients are vulnerable to develop severe form of COVID19 Infection. Although severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) mRNA vaccine has significantly…
  • 2022 American Transplant Congress

    Post-Simultaneous Kidney and Pancreas Transplant Outcomes in Type 2 Diabetes Compared to Type 1 Diabetes

    L. Liriano1, Y. Al Azzi2, S. Kapoor2, S. Jain1, M. Ajaimy3, P. Loarte2, C. Pynadath4, J. Graham2, S. Stefan1, E. Akalin5

    1Montefiore Medical Center, Bronx, NY, 2Montefiore Medical Center, New York, NY, 3Montefiore-Einstein Transplant Center, Scarsdale, NY, 4Montefiore Medical Center, Scarsdale, NY, 5Albert Einstein College of Medicine, Montefiore Medical Ctr, Bronx, NY

    *Purpose: To evaluate and compare short term and long-term outcomes in simultaneous kidney and pancreas transplant (SPK) recipients with a history of type 2 diabetes…
  • 2022 American Transplant Congress

    Fontan versus Non-Fontan Combined Heart-Liver Transplantation: Proceed but Cautiously

    I. A. Ziogas, W. K. Wu, M. Izzy, A. Shingina, C. Benson, K. L. Mishra, A. S. Shah, N. L. Do, W. G. McMaster, J. N. Menachem, S. P. Alexopoulos

    Vanderbilt University Medical Center, Nashville, TN

    *Purpose: Combined heart-liver transplantation (CHLT) is increasing, corresponding with a growing prevalence of Fontan-associated end-organ damage. We aimed to describe our contemporary institutional experience with…
  • « Previous Page
  • 1
  • …
  • 134
  • 135
  • 136
  • 137
  • 138
  • …
  • 1683
  • Next Page »

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences